No Data
Emerging markets stocks digest: Fulta continues to rise significantly, sea U sea hits the daily limit.
<4598> DELTA-P 533 +47 surged significantly. After the trading on the 28th, the progress of the phase 1/2 clinical trial of DFP-10917 and VEN was announced, which is considered a positive development. DFP-10917, when given as a low-dose continuous infusion, is believed to be highly safe, stops cancer cells in the G2/M phase, and induces apoptosis (programmed cell death). Therefore, a strong synergistic effect can be expected when combined with VEN (a BCL-2 inhibitor). Currently, a phase 1 clinical trial is underway.
Hot stocks digest (morning session): Sakura, LITALICO, Flutta, etc.
Trading at the daily price limit. The company announced its first-half financial results the previous day, with an operating profit of 1.3 billion yen, which is 5.2 times higher than the same period last year, exceeding the upward revised figure of 1.1 billion yen on September 20th.
Medical N--- significantly rose, announced a share buyback.
Significant gains. It was announced that a share buyback would be conducted after the close of trading on the 28th, which is considered a positive development.
Macnica Fuji, etc., announced a share buyback on October 28th.
The stocks that announced the establishment of a company stock acquisition frame on October 28 (Mon) are as follows: <3132> Macnica Fuji 2 million shares (1.1%) 3 billion yen (24/10/29-24/12/23) <3645> Medical N 0.4 million shares (4.4%) 0.1 billion yen (24/10/29-25/5/30) * The percentage in () of the number of shares represents the ratio to the total number of shares issued (excluding treasury stock). * The number of shares and amounts are the upper limits.
SBI SECURITIES holds 6.11% of shares in Medical Net(3645.JP)
On Oct 21, SBI SECURITIES submitted the Large Shareholding Report to Ministry of Finance to disclose its 6.11% ownership of the shares in $Medical Net(3645.JP)$. Source: Edinet AnnouncementWhat is
Toho, upward revision on 25/2, operating profit 620 billion yen←55 billion yen.
Toho <9602> announced a revision of its financial estimates for the fiscal year ending February 2025. Operating revenue was revised upward from 280 billion yen to 297 billion yen, and operating profit from 55 billion yen to 62 billion yen. With major hits in the film business such as "Crazy Rich House," "Detective Conan: The Crimson Love Letter," "Kingdom: The General and His Return," "The Last Mile," and the unexpected success of the sequel "Haikyu!! The Huge Dumpsite Showdown" generating box office revenue exceeding 11.5 billion yen from the previous consolidated fiscal year.
No Data
No Data